Clinical Trial Update: A Global Pregnancy Registry to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to YORVIPATH® (Palopegteriparatide) During Pregnancy and Breastfeeding

View source ↗

Summary

This clinical trial update describes a global pregnancy registry to collect maternal, fetal, and infant outcomes after exposure to YORVIPATH® (Palopegteriparati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoparathyroidism

Drugs mentioned

• YORVIPATH® (Palopegteriparatide) (Palopegteriparatide)

Snippet

Sponsor: Ascendis Pharma A/S | Conditions: Hypoparathyroidism | Status: RECRUITING